227
1. Cairo MS, Bishop M. Tumour lysis syndrome: new therapeutic strategies and classification. Br J Haematol. 2004;127(1):3-11.
2. Creutzig U, Zimmermann M, Reinhardt D, Dworzak M, Stary J, Lehrnbecher T. Early deaths and treatment-related mortality in children undergoing therapy for acute myeloid leukemia: analysis of the multicenter clinical trials AML-BFM 93 and AML-BFM 98. J Clin Oncol. 2004;22(21):4384-93.
3. Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis. 2011;52(4):e56-e93.
4. Goldman SC, Holcenberg JS, Finklestein JZ, Hutchinson R, Kreissman S, Johnson FL, et al. A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis. Blood. 2001;97(10):2998-3003.
5. Howard SC, Jones DP, Pui CH. The tumor lysis syndrome. N Engl J Med. 2011;364(19):1844-54.
6. Lehrnbecher T, Robinson P, Fisher B, Alexander S, Ammann RA, Beauchemin M, et al. Guideline for fever and neutropenia in children with cancer and hematopoietic stem-cell transplantation recipients: 2017 update. J Clin Oncol. 2017;35(18):2082-94.
7. Lewis MA, Hendrickson AW, Moynihan TJ. Oncologic emergencies: Pathophysiology, presentation, diagnosis, and treatment. CA Cancer J Clin. 2011 Sep-Oct;61(5):287-314. doi: 10.3322/caac.20124. Epub 2011 Aug 19. Erratum in: CA Cancer J Clin. 2011 Nov-Dec;61(6):420. Dosage error in article text. PMID: 21858793..
8. Quraishi NA, Palliyil N, Hassanin MA, D'Aquino D, Shetaiwi A, Walker D. Malignant spinal cord compression in the paediatric population-a systematic review, meta-analysis. Eur Spine J. 2023 Dec;32(12):4306-4313.
9. Rosner MH, Perazella MA. Acute kidney injury in patients with cancer. Kidney Int. 2019;95(6):1314-26.
10. Ruggiero A, Rizzo D, Amato M, Riccardi R. Management of Hyperleukocytosis. Curr Treat Options Oncol. 2016 Feb;17(2):7.
11. Vincent F, Darmon M. Tumor Lysis Syndrome in the 21st Century: To Recreate Risk Factors and Prognosis? Oncologist. 2018 Dec;23(12):e162.